Kliebe C, Nies B A, Meyer J F, Tolxdorff-Neutzling R M, Wiedemann B
Antimicrob Agents Chemother. 1985 Aug;28(2):302-7. doi: 10.1128/AAC.28.2.302.
A clinical isolate of Klebsiella ozaenae with transferable resistance to broad-spectrum cephalosporins produces a beta-lactamase determined by plasmid pBP60. The beta-lactamase had the same isoelectric point as SHV-1 (7.6). From heteroduplex analysis, an extensive homology between the two bla genes could be deduced; therefore, the new beta-lactamase was designated SHV-2. Enzymatic studies revealed that SHV-2 was able to hydrolyze broad-spectrum cephalosporins due to an increased affinity of these compounds for the enzyme. The assumption that SHV-2 is a natural mutant of SHV-1 was strongly supported by the isolation of a laboratory mutant of SHV-1 that showed activities similar to those of SHV-2.
一株对广谱头孢菌素具有可转移耐药性的鼻硬结克雷伯菌临床分离株产生了一种由质粒pBP60决定的β-内酰胺酶。该β-内酰胺酶的等电点与SHV-1相同(7.6)。通过异源双链分析,可以推断出两个bla基因之间存在广泛的同源性;因此,新的β-内酰胺酶被命名为SHV-2。酶学研究表明,由于这些化合物对该酶的亲和力增加,SHV-2能够水解广谱头孢菌素。SHV-1的实验室突变体的分离强烈支持了SHV-2是SHV-1的天然突变体这一假设,该突变体表现出与SHV-2相似的活性。